
PR Happenings at KCSA Strategic Communications, Huntsworth, Trevelino/Keller, and Stagwell Group
KCSA Strategic Communications Signs as AOR for Marina Biotech’s Investor Counsel New York-based KCSA Strategic Communications will handle the investor relations communications program for Marina Biotech, Inc. (OTCQB: MRNA), a biopharma corp developing and commercializing innovative treatments for cancer, hypertension, arthritis, and disease intersections. KCSA plans to bring awareness of